Transcription_NN
factor_NN
GATA-3_NN
is_VBZ
differentially_RB
expressed_VBN
in_IN
murine_JJ
Th1_NN
and_CC
Th2_NN
cells_NNS
and_CC
controls_VBZ
Th2-specific_JJ
expression_NN
of_IN
the_DT
interleukin-5_NN
gene_NN
._.

Interleukin-5_NN
-LRB-_-LRB-
IL-5_NN
-RRB-_-RRB-
,_,
which_WDT
is_VBZ
produced_VBN
by_IN
CD4_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
T_NN
helper_NN
2_CD
-LRB-_-LRB-
Th2_NN
-RRB-_-RRB-
cells_NNS
,_,
but_CC
not_RB
by_IN
Th1_NN
cells_NNS
,_,
plays_VBZ
a_DT
key_JJ
role_NN
in_IN
the_DT
development_NN
of_IN
eosinophilia_NN
in_IN
asthma_NN
._.

Despite_IN
increasing_VBG
evidence_NN
that_IN
the_DT
outcome_NN
of_IN
many_JJ
diseases_NNS
is_VBZ
determined_VBN
by_IN
the_DT
ratio_NN
of_IN
the_DT
two_CD
subsets_NNS
of_IN
CD4_NN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
T_NN
helper_NN
cells_NNS
,_,
Th1_NN
and_CC
Th2_NN
,_,
the_DT
molecular_JJ
basis_NN
for_IN
Th1_NN
-_:
and_CC
Th2-specific_JJ
gene_NN
expression_NN
remains_VBZ
to_TO
be_VB
elucidated_VBN
._.

We_PRP
previously_RB
established_VBD
a_DT
critical_JJ
role_NN
for_IN
the_DT
transcription_NN
factor_NN
GATA-3_NN
in_IN
IL-5_NN
promoter_NN
activation_NN
in_IN
EL-4_NN
cells_NNS
,_,
which_WDT
express_VBP
both_CC
Th1_NN
-_:
and_CC
Th2-type_JJ
cytokines_NNS
._.

Our_PRP$
studies_NNS
reported_VBN
here_RB
demonstrate_VBP
that_IN
GATA-3_NN
is_VBZ
critical_JJ
for_IN
expression_NN
of_IN
the_DT
IL-5_NN
gene_NN
in_IN
bona_FW
fide_FW
Th2_NN
cells_NNS
._.

Whereas_IN
mutations_NNS
in_IN
the_DT
GATA-3_NN
site_NN
abolished_VBD
antigen_NN
-_:
or_CC
cAMP-stimulated_JJ
IL-5_NN
promoter_NN
activation_NN
in_IN
Th2_NN
cells_NNS
,_,
ectopic_JJ
expression_NN
of_IN
GATA-3_NN
in_IN
Th1_NN
cells_NNS
or_CC
in_IN
a_DT
non-lymphoid_JJ
,_,
non-IL-5-producing_JJ
cell_NN
line_NN
activated_VBD
the_DT
IL-5_NN
promoter_NN
._.

During_IN
the_DT
differentiation_NN
of_IN
naive_JJ
CD4_NN
-LRB-_-LRB-
+_JJ
-RRB-_-RRB-
T_NN
cells_NNS
isolated_VBN
from_IN
T_NN
cell_NN
receptor_NN
transgenic_JJ
mice_NNS
,_,
GATA-3_NN
gene_NN
expression_NN
was_VBD
up-regulated_VBN
in_IN
developing_VBG
Th2_NN
cells_NNS
,_,
but_CC
was_VBD
down-regulated_VBN
in_IN
Th1_NN
cells_NNS
,_,
and_CC
antigen_NN
-_:
or_CC
cAMP-activated_JJ
Th2_NN
cells_NNS
-LRB-_-LRB-
but_CC
not_RB
Th1_NN
cells_NNS
-RRB-_-RRB-
expressed_VBD
the_DT
GATA-3_NN
protein_NN
._.

Thus_RB
,_,
GATA-3_NN
may_MD
play_VB
an_DT
important_JJ
role_NN
in_IN
the_DT
balance_NN
between_IN
Th1_NN
and_CC
Th2_NN
subsets_NNS
in_IN
immune_JJ
responses_NNS
._.

Inhibition_NN
of_IN
GATA-3_NN
activity_NN
has_VBZ
therapeutic_JJ
potential_NN
in_IN
the_DT
treatment_NN
of_IN
asthma_NN
and_CC
other_JJ
hypereosinophilic_JJ
diseases_NNS
._.

